Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus

Epilepsy Research

Volumn 28, Issue 2, 1997, Pages 143-153

  Okada, Motohiro ^a   Hirano, Takayuki ^b   Mizuno, Kazuhisa ^a   Chiba, Takeshi ^a   Kawata, Yuko ^a   Kiryu, Kazuhiro ^a   Wada, Kazumaru ^a   Tasaki, Hiroichi ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b National Hospital Organization Hanamaki Hospital   (Japan)

Author keywords

Carbamazepine; DOPA accumulation; Dopamine; Epilepsy; Microdialysis

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; 3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CARBAMAZEPINE; DOPA; DOPAMINE; HOMOVANILLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; ENZYME ACTIVITY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CARBAMAZEPINE; CORPUS STRIATUM; DOPAMINE; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR;

EID: 0030873358     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(97)00042-9     Document Type: Article

References (46)

1. 2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacol 1990;29:657-61.
2. Barros HMT, Braz S, Leite R. Effects of carbamazepine on dopamine release and reuptake in rat striatal slices. Epilepsia 1986;27:534-7.
3. Chadwick D, Reynolds HH, Marsden CD. Anticonvulsant induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatry 1976;39:1210-8.
4. Dalkin T, Lee AS. Carbamazepine and forme fruste neuroleptic malignant syndrome. Br J Psychiatry 1990;157:437-8.
5. Elphick, M. Effects of carbamazepine on dopamine function in rodents. Psychopharmacology 1989;99:532-536.
6. Ferraro, G., Vella, N., Sardo, P., Caravaglios, G., Sabatino, M., LaGrutta, V. Dopaminergic control of feline hippocampal epilepsy: a nigrohippocampal pathway. Neurosci Lett 1991;123:41-44.
7. Fromm, G.H., Terrence, C.F., Maroon, J.C., Trigeminal neuralgia. Current concepts regarding etiology and pathogenesis. Arch Neurol 1984;41:1204-1207.
8. Glowinski, J., Iversen, L. Regional studies of catecholamines in the rat brain. J Neurochem 1966;13:665-669.
9. Hirano, T., Kaneko, S., Otani, K., Kondo, T., Sasa, H., Fukushima, Y. Mechanisms of antimanic effects of zotepine. Neurosciences 1990;16:511-516.
10. Juergens, U. Simultaneous determination of zonisamide and nine other anti-epilepitc drugs and metabolites in serum. J Chromatogr 1987;385:233-240.
11. Kanazawa, C., Sawada, S., Ohno-Shosaku, T. Suppression of hippocampal synaptic transmission by the spider toxin ω-agatoxin-IV-A. Brain Res 1994;634:349-352.
12. Kaneko, S., Fukushima, Y., Sato, T., Hiramatsu, M., Mori, A. Effects of carbamazepine on catecholmaine level in mouse brain. IRCS Med Sci 1980;9:80-81.
13. Kaneko, S., Okada, M., Hirano, T., Kondo, T., Otani, K., Fukushima, Y. Carbamazepine and zonisaide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine dose not antagonize adenosine effect in vitro: mechanisms of blockade of seizure spread. Jpn J Psychiatry Neurol 1993;47:371-373.
14. Keck, P.E.J., McElroy, S.L., Friedman, L.M. Valproate and carbamazepine in the treatment of panic and post-traumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 1992;12:36S-41S.
15. Kito, M., Maehara, M., Watanabe, K. Antiepileptic drugs-calcium current interaction in cultured human neuroblastoma cells. Seizure 1994;3:141-149.
16. Kochli, H. von Wartburg, J.P. A sensitive photometric assay for monoamine oxidase. Anal Biochem 1978;84:127-135.
17. Loiseau P, Duche B. Carbamazepine clinical use. In: Levy RH, Mattson RH, Meldrum BS, editors. Antiepileptic Drugs. 4th ed. New York: Ravan Press, 1995:555-566.
18. Loscher, W., Czuczwar, S.J. Studies on involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy. Eur J Pharmacol -65.
19. Macdonald RL. Carbamazepine, mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, editors. Antiepileptic Drugs. 4th ed. New York: Raven Press, 1995:491-498.
20. Marangos, P.J., Post, R.M., Patel, J., Zander, A., Weiss, S.R.B. Specific and potent interactions of carbamazepine with brain adensoine receptors. Eur J Pharmacol 1983;93:175-182.
21. Masuda, Y., Utsui, Y., Shiraishi, Y., Karasawa, T., Yoshida, K., Shimizu, M. Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl - 1,2-benzisoxazole (AD810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals. Epilepsia 1979;20:623-633.
22. Mizuno, K., Okada, M., Kaneko, S., Hirano, T., Tokinaga, N., Chiba, T., Otani, K., Fukushima, Y. Effects of zonisamide, carbamazepine and valproate on monoamine metabolism in rat striatum and hippocampus. Jpn J Psychiatry Neurol 1994;48:406-408.
23. Moghaddam, B., Bunney, B.S. Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J Neuorchem 1989;53:652-654.
24. Neppe, V.M. Carbamazepine in the psychiatric patient. Lancet 1982;2:334.
25. Nibuya, M., Kanba, S., Kinoshita, N., Suzuki, E., Yagi, G., Nakaki, T., Kato, R. Effects of carbamazepine and Ipsapirone on turnover of monoamine in the rat brain. Jpn J Psychaitry Neurol 1991;45:127-128.
26. Nakahara, D., Ozaki, N., Kapoor, V., Nagatsu, T. The effect of uptake inhibition on dopamine release from the nucleus accumbens of rats during self- or forced stimulation of the medical forebrain bundle: a microdialysis study. Neuroscience Lett 1989;104:136-140.
27. 2+ depend dopamine release. Epilepsy Res 1992;13:113-119.
28. Okada, M., Kaneko, S., Hirano, T., Mizuno, K., Kondo, T., Otani, K., Fukushima, Y. Effects of zonisamide on dopaminergic system. Epilepsy Res 1995;22:193-205.
29. Okdad, M., Mizuno, K., Kaneko, S. Magnesium ion augmentation of inhibitory effects of adenosine on dopamine release in the rat striatum. Psychiatry Clin Neuorsci 1996a;50:147-156.
30. 2 receptors modulate extracellular dopamine leels in rat striatum. Neuroscience Lett 1996b;212:53-56.
31. Okada, M., Kiryu, K., Kawata, Y., Mizuno, K., Wada, K., Tasaki, H., Kaneko, S. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur J Pharmacol 1997;321:181-188.
32. Okuma, T., Yamashita, I., Takahashi, R., Itoh, H., Otuki, S., Watanabe, S., Hazama, H., Inagawa, K. Comparison of the antimanic efficacy of carbamazepine and lithium carbanate by double-blind controlled study. Parmacopsychiatry 1990;23:143-150.
33. Pani, L., Kuzmin, A., Diana, M., De Montis, G., Gessa, G.L., Rossetti, Z.L. Calcium receptor antagonists modify cocain effects in the central nervous system differently. Eur J Pharmacol 1990;190:217-221.
34. Parson, D.F., Williams, G.R. Isolation and purification of the outer membrane and inner membrane of liver mitochondria. Meth Enzymol 1967;10:443-448.
35. Qunttrone, A., Crunelli, V., Samanin, R. Seizure susceptibility and anticonvulsant activity of carbamazepine, diphenylhydantoin and phenobarbital in rats with selectie depletions of brain monoamines. Neuropharmacol 1978;17:643-647.
36. Schwarz, J.R., Grigat, G. Phenytoin and carbamazepine: Potential- and frequency-dependent block of Na currents in mammalian nerve fibers. Epilepsia 1989;30:286-294.
37. Troupin, A.S., Ojemann, L.M. Paradoxical intoxication - a complication of anticonvulsant administration. Epilepsia 1975;16:753-758.
38. Yoshimura, R., Yanagihara, N., Terao, T., Minami, L. Abe, K., Izumi, F. Inhibition by carbamazepine of various ion channels-mediated catecholamine secretion in cultured bovine adrenal medullary cells. Naunyn-Schmiedeberg's Arch Pharmacol 1995;352:297-303.
39. Waldmeier, P.C., Baumann, P.A., Fehr, B., Ce Herdt, P., Maitre, L. Carbamazepine decreases catecholamine turnover in the rat brain. J Pharmacol Exp Ther 1984;231:166-172.
40. 2 agonist LY 17155 into the nucleus accumbens of amygdala - kindled rats. Brain Res 1991;553:181-187.
41. Weaver, D.F., Camfield, P., Fraser, A. Massive carbamazepine overdose: clinical and pharmacologic observations in five episodes. Neurology 1988;38:755-759.
42. Westerink, B.H.C., Damsma, G., Rollema, H., De Vries, J.B., Horn, A.S. Scope and limitation of in vivo brain dialysis: A comparison of its application to various neurotransmitter systems. Life Sci 1987;41:1763-1776.
43. Westerink, B.H.C., DeVries, J.B., Duran, R. Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats. J Neurochem 1990;54:381-387.
44. 2+ channels in supporting hippocampal synaptic transmission. Science 1994;264:107-111.
45. Willner P. Dopaminergic mechanisms in depression and mania. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology. New York: Raven Press, 1995:921-931.
46. Zhang, Y.X., Yamashita, H., Ohshita, T., Sawamoto, N., Nakamura, S. ATP increases extracellular dopamine level through stimulation of P2Y purinoceptors in the rat striatum. Brain Res 1995;691:205-212.